524 related articles for article (PubMed ID: 15508104)
1. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms.
Bréchot C
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S56-61. PubMed ID: 15508104
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus induced hepatocellular carcinoma.
Chemin I; Zoulim F
Cancer Lett; 2009 Dec; 286(1):52-9. PubMed ID: 19147276
[TBL] [Abstract][Full Text] [Related]
3. Expression of a hepatitis B virus pre-S2 deletion mutant in the liver results in hepatomegaly and hepatocellular carcinoma in mice.
Teng YC; Neo JC; Wu JC; Chen YF; Kao CH; Tsai TF
J Pathol; 2017 Mar; 241(4):463-474. PubMed ID: 27868197
[TBL] [Abstract][Full Text] [Related]
4. Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma.
Han YF; Zhao J; Ma LY; Yin JH; Chang WJ; Zhang HW; Cao GW
World J Gastroenterol; 2011 Oct; 17(38):4258-70. PubMed ID: 22090781
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection.
Pollicino T; Squadrito G; Cerenzia G; Cacciola I; Raffa G; Craxi A; Farinati F; Missale G; Smedile A; Tiribelli C; Villa E; Raimondo G
Gastroenterology; 2004 Jan; 126(1):102-10. PubMed ID: 14699492
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma.
Chaturvedi VK; Singh A; Dubey SK; Hetta HF; John J; Singh MP
Microb Pathog; 2019 Mar; 128():184-194. PubMed ID: 30611768
[TBL] [Abstract][Full Text] [Related]
7. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
[TBL] [Abstract][Full Text] [Related]
8. Risk stratification for hepatitis B virus related hepatocellular carcinoma.
Lin CL; Kao JH
J Gastroenterol Hepatol; 2013 Jan; 28(1):10-7. PubMed ID: 23094699
[TBL] [Abstract][Full Text] [Related]
9. Different pre-S deletion patterns and their association with hepatitis B virus genotypes.
Chen BF
World J Gastroenterol; 2016 Sep; 22(35):8041-9. PubMed ID: 27672298
[TBL] [Abstract][Full Text] [Related]
10. Naturally occurring hepatitis B surface gene variants in chronic hepatitis B virus infection: correlation with viral serotypes and clinical stages of liver disease.
Liu CJ; Kao JH; Shau WY; Chen PJ; Lai MY; Chen DS
J Med Virol; 2002 Sep; 68(1):50-9. PubMed ID: 12210430
[TBL] [Abstract][Full Text] [Related]
11. Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection.
Kannangai R; Molmenti E; Arrazola L; Klein A; Choti M; Thomas DL; Torbenson M
J Viral Hepat; 2004 Jul; 11(4):297-301. PubMed ID: 15230851
[TBL] [Abstract][Full Text] [Related]
12. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus and hepatocellular carcinoma.
Arbuthnot P; Kew M
Int J Exp Pathol; 2001 Apr; 82(2):77-100. PubMed ID: 11454100
[TBL] [Abstract][Full Text] [Related]
14. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.
Ringelhan M; O'Connor T; Protzer U; Heikenwalder M
J Pathol; 2015 Jan; 235(2):355-67. PubMed ID: 25196558
[TBL] [Abstract][Full Text] [Related]
15. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K
Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132
[TBL] [Abstract][Full Text] [Related]
16. Frequency and Characteristics of Occult Hepatitis B Infection Among Hepatocellular Carcinoma Patients in Japan.
Muto J; Sugiyama M; Shirabe K; Mukaide M; Kirikae-Muto I; Ikegami T; Yoshizumi T; Yamashita YI; Maehara Y; Mizokami M
Ann Hepatol; 2018 July - August ,; 17(4):596-603. PubMed ID: 29893701
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.
Lin CL; Kao JH
J Biomed Sci; 2008 Mar; 15(2):137-45. PubMed ID: 18058038
[TBL] [Abstract][Full Text] [Related]
18. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG
Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152
[TBL] [Abstract][Full Text] [Related]
19. Perspectives and control of hepatitis B virus infection in Taiwan.
Lin CL; Kao JH
J Formos Med Assoc; 2015 Oct; 114(10):901-9. PubMed ID: 26184565
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC): molecular mechanisms and novel paradigms.
Brechot C; Kremsdorf D; Soussan P; Pineau P; Dejean A; Paterlini-Brechot P; Tiollais P
Pathol Biol (Paris); 2010 Aug; 58(4):278-87. PubMed ID: 20667665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]